Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Loscertales

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Oncology Research|March 20, 2025
T-cell prolymphocytic leukemia, a case report and review of the literatureLuis Manuel GONZáLEZ-RODRíGUEZ, Luis Miguel JUáREZ-Salcedo, Javier Loscertales, et al.
Experimental Hematology|May 22, 2010
Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemiaCarlos Cuesta-Mateos, Sonia López-Giral, Manuel Alfonso-Pérez, et al.
British Journal of Haematology|June 11, 2020
Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)Pau Abrisqueta, Julio Delgado, Miguel Alcoceba, et al.
Medicina Clinica|February 26, 2017
Update of the Grupo Español de Leucemia Linfocítica Crónica clinical guidelines of the management of chronic lymphocytic leukemiaJosé A García-Marco, Julio Delgado, José A Hernández-Rivas, et al.
Cancers|August 26, 2023
Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL StudyJavier Loscertales, Pau Abrisqueta-Costa, Antonio Gutierrez, et al.
Cancers|December 17, 2024
Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL StudyPau Abrisqueta-Costa, José Antonio García-Marco, Antonio Gutiérrez, et al.
Medicina Clinica|January 11, 2025
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma from Chronic Lymphocytic Leukemia Spanish Group (GELLC)Ángeles Medina, Ana Muntañola, Marta Crespo, et al.
British Journal of Haematology|August 7, 2012
Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trialWolfgang U Knauf, Toshko Lissitchkov, Ali Aldaoud, et al.
Leukemia & Lymphoma|January 4, 2018
Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS studyPaula Cramer, Graeme Fraser, Rodrigo Santucci-Silva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemiaWolfgang U Knauf, Toshko Lissichkov, Ali Aldaoud, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Oncology Research|March 20, 2025
T-cell prolymphocytic leukemia, a case report and review of the literatureLuis Manuel GONZáLEZ-RODRíGUEZ, Luis Miguel JUáREZ-Salcedo, Javier Loscertales, et al.
Experimental Hematology|May 22, 2010
Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemiaCarlos Cuesta-Mateos, Sonia López-Giral, Manuel Alfonso-Pérez, et al.
British Journal of Haematology|June 11, 2020
Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)Pau Abrisqueta, Julio Delgado, Miguel Alcoceba, et al.
Medicina Clinica|February 26, 2017
Update of the Grupo Español de Leucemia Linfocítica Crónica clinical guidelines of the management of chronic lymphocytic leukemiaJosé A García-Marco, Julio Delgado, José A Hernández-Rivas, et al.
Cancers|August 26, 2023
Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL StudyJavier Loscertales, Pau Abrisqueta-Costa, Antonio Gutierrez, et al.
Cancers|December 17, 2024
Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL StudyPau Abrisqueta-Costa, José Antonio García-Marco, Antonio Gutiérrez, et al.
Medicina Clinica|January 11, 2025
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma from Chronic Lymphocytic Leukemia Spanish Group (GELLC)Ángeles Medina, Ana Muntañola, Marta Crespo, et al.
British Journal of Haematology|August 7, 2012
Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trialWolfgang U Knauf, Toshko Lissitchkov, Ali Aldaoud, et al.
Leukemia & Lymphoma|January 4, 2018
Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS studyPaula Cramer, Graeme Fraser, Rodrigo Santucci-Silva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemiaWolfgang U Knauf, Toshko Lissichkov, Ali Aldaoud, et al.
Pageof 5